Robert C. Yang

Robert C. Yang has over 10 years of experience serving as counsel to public companies during stages of substantial growth, mainly in the biotechnology industry. Prior to joining Elevation Oncology, he was Executive Director and Assistant General Counsel at REGENXBIO, a leading gene therapy company, where he advised on several major capital markets and corporate development transactions in addition to legal matters across all business functions. Earlier in his career, Robert was an associate at the international law firm of Gibson, Dunn & Crutcher, where he practiced in the areas of capital markets, securities regulation and corporate governance. He received his J.D. with honors from New York University School of Law and his B.S. in Economics from Duke University.